Trial Profile
A prospective study for the efficacy and safety of Telbivudine in hepatitis B virus infected pregnant woman to prevent mother-child transmission.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 20 Sep 2011 New trial record